Tempus Ai Cl A (TEM) Stock Price, Quote & News

Company Profile

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also...

Industry: Health Information Services

Sector: Healthcare

Phone: 800 976 5448

Fax: 800 893 0276

Website: www.tempus.com

Address:

600 West Chicago Avenue, Suite 510, Chicago, United States

farDoc Jul. 9 at 3:14 AM

$TEM I'm grateful to live in a time when technology helps spread encouraging, Bible-centered music across the globe. As a Christian creator, I'm using today's creative tools to glorify God through cinematic worship. 🎶 Epic316Music | Reformed Bible-centered cinematic worship https://push.fm/fl/3g00pnnr ▶️ Full Songs & Videos https://www.youtube.com/@Epic316Music 📘 Facebook https://www.facebook.com/share/173N5Jby6b/ ☕ Support the ministry https://buymeacoffee.com/Epic316Music

1 · Reply

LoveRetailFroth Jul. 9 at 1:27 AM

$SANA Poor SOBs who shorted or sold today! 😂🚀🚀🚀🍺 $AMLX $TEM $RXRX $VIVO

0 · Reply

DeepSeaTurtle Jul. 8 at 11:07 PM

I identified these investment opportunities-offering potential upside over a 2-to-3-year horizon and the prospect of a tenfold return-at an early stage of the cycle. The key is not chasing - but recognizing asymmetric setups before the crowd. $AAOI +400% ~ +1000% $TEM +400% ~ +1000% $NBIS +500% ~ +1000% $RXRX +500% ~ +1200% $ASTS +500% ~ +1500% I often get asked why I don’t turn this into paid content, but for me, sharing stock information is just a hobby. I’m not financially struggling, so I choose to share it for free. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.

0 · Reply

SwingTraderPro1 Jul. 8 at 9:23 PM

Here are 10 companies that I believe have 10x potential over the next 1–3 years. $ALAB current price $392 $CIFR current price $21 $ONDS current price $7.5 $TEM current price $56 Note: Opportunities for 10x returns are typically accompanied by interim drawdowns of 50%–70%; therefore, it is advisable to build your position in stages rather than going all-in at once. A new alert will be released shortly. For timely execution, real-time notifications are recommended, as delayed updates may result in missed entry opportunities.

1 · Reply

I_am_back_2day Jul. 8 at 8:49 PM

$TEM couldn’t stay above 57.. sold everything will start buying back at 53

1 · Reply

rapchikk Jul. 8 at 8:09 PM

$TEM Will not rise until consistent inside selling stops. Too much stock based compensation to employees and CEO.

0 · Reply

I_am_back_2day Jul. 8 at 7:48 PM

$TEM anything above 57 is good today

0 · Reply

DeepSeaTurtle Jul. 8 at 7:42 PM

My Elliott Wave Price Targets: Mapping potential market structure and wave-based projections for key moves ahead. $UUUU → $44 $TEM → $165 $RDW → $70 $GLXY → $64 $ONDS → $25 Head back to my profile to get the latest trading strategies and market analysis. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.

0 · Reply

asanka79 Jul. 8 at 7:05 PM

$TEM momentum gone 57 is like a wall

0 · Reply

QulckTrade Jul. 8 at 6:56 PM

$TEM come on give some good news tomorrow so we can fly.

0 · Reply

Tempus AI initiated with a Hold at Freedom Capital

2026-06-25T12:35:24.000Z - 13 days ago

Tempus AI announces research collaboration with Angiosarcoma Awareness

Jun 25, 2026, 8:30 AM EDT - 13 days ago

Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

Jun 16, 2026, 5:07 PM EDT - 22 days ago

Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms

2026-06-11T12:35:47.000Z - 27 days ago

Tempus AI announces publication of multi-center validation of software

Jun 11, 2026, 8:30 AM EDT - 27 days ago

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Jun 9, 2026, 6:00 AM EDT - 4 weeks ago

Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing

Jun 8, 2026, 2:00 PM EDT - 4 weeks ago

Tempus AI Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 5, 2026, 4:01 PM EDT - 4 weeks ago

Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

2026-06-03T15:31:34.000Z - 5 weeks ago

Tempus AI launches open-source digital pathology consortium

Jun 3, 2026, 8:30 AM EDT - 5 weeks ago

Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members

2026-06-01T20:50:18.000Z - 5 weeks ago

Tempus AI assumed with a Peer Perform at Wolfe Research

2026-06-01T14:49:15.000Z - 5 weeks ago

Tempus AI announced the upcoming clinical availability of xH

Jun 1, 2026, 8:30 AM EDT - 5 weeks ago

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

2026-05-31T21:05:57.000Z - 5 weeks ago

Short Report: Tempus AI short interest at record high

BOBS FIG RUM

2026-05-31T13:35:04.000Z - 5 weeks ago

Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs

2026-05-31T13:25:04.000Z - 5 weeks ago

Tempus AI announces introduction of Tempus Preview

May 31, 2026, 8:30 AM EDT - 5 weeks ago

Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development

May 30, 2026, 8:30 AM EDT - 5 weeks ago

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

May 30, 2026, 8:00 AM EDT - 5 weeks ago

Tempus Introduces ‘Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results

2026-05-29T14:36:26.000Z - 5 weeks ago

Tempus AI expects 25% top-line growth over next 3 years

2026-05-29T14:35:02.000Z - 5 weeks ago

Tempus AI reiterates FY26 revenue view of $1.59B-$1.6B, consensus $1.59B

2026-05-29T13:35:50.000Z - 5 weeks ago

Tempus AI announces initial results from Multimodal Foundation Model efforts

May 29, 2026, 9:15 AM EDT - 5 weeks ago

Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology

May 29, 2026, 9:00 AM EDT - 5 weeks ago

Tempus AI Transcript: Investor Day 2026

May 29, 2026, 9:00 AM EDT - 5 weeks ago

Tempus AI Slides: FY 2026

2026-05-29T12:52:31.000Z - 5 weeks ago

Tempus AI receives FDA approval for tumor-only xT CDx

May 29, 2026, 8:15 AM EDT - 5 weeks ago

Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio

May 28, 2026, 8:30 AM EDT - 5 weeks ago

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

May 27, 2026, 8:33 AM EDT - 6 weeks ago

Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

May 26, 2026, 8:30 AM EDT - 6 weeks ago

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

May 21, 2026, 8:30 AM EDT - 6 weeks ago

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

BMY

May 11, 2026, 6:00 AM EDT - 2 months ago

Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

May 8, 2026, 12:59 AM EDT - 2 months ago

Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

May 7, 2026, 7:11 AM EDT - 2 months ago

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

May 6, 2026, 8:00 AM EDT - 2 months ago

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

QTRX

May 5, 2026, 4:30 PM EDT - 2 months ago

Tempus AI Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Tempus AI Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Tempus AI Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Tempus AI Quarterly report: Q1 2026

May 5, 2026, 4:01 PM EDT - 2 months ago

Tempus Reports First Quarter 2026 Results

Apr 29, 2026, 8:30 AM EDT - 2 months ago

Tempus to Host Inaugural Investor Day on May 29, 2026

Apr 28, 2026, 8:30 AM EDT - 2 months ago

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Apr 21, 2026, 8:30 AM EDT - 2 months ago

Tempus to Report First Quarter 2026 Financial Results on May 5

Apr 15, 2026, 8:30 AM EDT - 3 months ago

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Apr 14, 2026, 11:45 AM EDT - 3 months ago

Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 14, 2026, 8:30 AM EDT - 3 months ago

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Apr 13, 2026, 8:30 AM EDT - 3 months ago

Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

GILD

Apr 8, 2026, 4:01 PM EDT - 3 months ago

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Apr 7, 2026, 8:00 AM EDT - 3 months ago

Tempus AI Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 3 months ago

Tempus AI Proxy statement: Proxy filing

Apr 1, 2026, 8:30 AM EDT - 3 months ago

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Mar 17, 2026, 8:30 AM EDT - 4 months ago

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Mar 11, 2026, 8:30 AM EDT - 4 months ago

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Mar 3, 2026, 12:15 PM EST - 4 months ago

Tempus AI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Mar 3, 2026, 8:30 AM EST - 4 months ago

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Feb 26, 2026, 8:30 AM EST - 4 months ago

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Feb 24, 2026, 4:30 PM EST - 4 months ago

Tempus AI Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 4 months ago

Tempus AI Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 4 months ago

Tempus AI Earnings release: Q4 2025

Feb 24, 2026, 4:30 PM EST - 4 months ago

Tempus AI Slides: Q4 2025

Feb 24, 2026, 4:01 PM EST - 4 months ago

Tempus Reports Fourth Quarter and Full Year 2025 Results

Feb 19, 2026, 11:01 AM EST - 4 months ago

Is TEM Stock A Buy At $60?

Feb 18, 2026, 8:30 AM EST - 5 months ago

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Feb 12, 2026, 4:05 PM EST - 5 months ago

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Feb 12, 2026, 4:05 PM EST - 5 months ago

Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States

Feb 10, 2026, 8:30 AM EST - 5 months ago

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Feb 4, 2026, 7:00 AM EST - 5 months ago

Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

Feb 2, 2026, 7:00 AM EST - 5 months ago

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Jan 27, 2026, 8:30 AM EST - 5 months ago

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Jan 26, 2026, 11:14 AM EST - 5 months ago

Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto Transport

Jan 21, 2026, 8:30 AM EST - 6 months ago

Tempus Announces the Launch of Paige Predict

Jan 12, 2026, 4:30 PM EST - 6 months ago

Tempus AI Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 4:30 PM EST - 6 months ago

Tempus AI Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 8:30 AM EST - 6 months ago

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Jan 12, 2026, 8:00 AM EST - 6 months ago

Here's why the Tempus AI stock may surge 47% soon

Jan 12, 2026, 7:00 AM EST - 6 months ago

Northwestern Medicine Selects Tempus to Expand Genomic Testing

farDoc Jul. 9 at 3:14 AM

1 · Reply

LoveRetailFroth Jul. 9 at 1:27 AM

$SANA Poor SOBs who shorted or sold today! 😂🚀🚀🚀🍺 $AMLX $TEM $RXRX $VIVO

0 · Reply

DeepSeaTurtle Jul. 8 at 11:07 PM

0 · Reply

SwingTraderPro1 Jul. 8 at 9:23 PM

1 · Reply

I_am_back_2day Jul. 8 at 8:49 PM

$TEM couldn’t stay above 57.. sold everything will start buying back at 53

1 · Reply

rapchikk Jul. 8 at 8:09 PM

$TEM Will not rise until consistent inside selling stops. Too much stock based compensation to employees and CEO.

0 · Reply

I_am_back_2day Jul. 8 at 7:48 PM

$TEM anything above 57 is good today

0 · Reply

DeepSeaTurtle Jul. 8 at 7:42 PM

0 · Reply

asanka79 Jul. 8 at 7:05 PM

$TEM momentum gone 57 is like a wall

0 · Reply

QulckTrade Jul. 8 at 6:56 PM

$TEM come on give some good news tomorrow so we can fly.

0 · Reply

mercar9897 Jul. 8 at 6:22 PM

$TEM patience we will see $75

0 · Reply

I_am_back_2day Jul. 8 at 6:04 PM

$TEM I think I should stop selling.. once I sell, price is falling.. if I buy back it’s going back up again.. let me stop selling from that onwards.. swing trading with fear is bad for mental health..

0 · Reply

KryptonResearch Jul. 8 at 5:49 PM

AI-enabled healthcare/research is the most obvious massive winner… $ABCL $SLS $RXRX $IBRX $TEM etc… We take a look at a lesser known name in this space, with similar, if not greater upside potential given their ownership of the data layer. This is the next big sector, we have our pick, but there are so many names that will pay well. https://kryptonresearch.substack.com/p/blood-money

0 · Reply

BullYa Jul. 8 at 5:24 PM

$TEM retest & will buy 📉… $50

0 · Reply

DailyWatcher_ Jul. 8 at 4:48 PM

The growth stock investing script: If you own names like $NVDA, $AMD, $PLTR, $CRWV, or $TEM: sell into every all-time high then set alerts at -40%, -45%, -50%, and -60% drawdowns buy back in at the bottom slowly trim during extra green days cash out again at new ATHs. repeat the script This is how you win. The old-school long-term investor mindset has become outdated (except for a few rare exceptions).

1 · Reply

Andrewsan85 Jul. 8 at 4:11 PM

$TEM which direction will it go till friday?

0 · Reply

Clemens300 Jul. 8 at 4:03 PM

$TEM Oh well. Maybe next year.

0 · Reply

I_am_back_2day Jul. 8 at 3:40 PM

$TEM people who missed rally can join back..

0 · Reply

AcceleratorModel Jul. 8 at 2:59 PM

$TEM added 57s

0 · Reply

I_am_back_2day Jul. 8 at 2:54 PM

$TEM ride now as I bought back most of the stocks I sold at 62

0 · Reply

smartwork5678 Jul. 8 at 2:51 PM

Today's quick view $CNET - Watching if the momentum lasts. $SOUN - AI hype needs follow-through. $TEM - Still an interesting AI name.

2 · Reply

I_am_back_2day Jul. 8 at 2:49 PM

$TEM Wild swings

0 · Reply

Market Cap	10.79B
Revenue (ttm)	1.27B
Net Income (ttm)	-245.03M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.27%
Debt to Equity Ratio	0.73

Volume	4,746,700
Avg Vol	6,715,426
Day's Range	N/A - N/A
Shares Out	179.57M
Stochastic %K	45%
Beta	3.46
Analysts	Sell
Price Target	$66.06